Last $37.52 USD
Change Today +0.17 / 0.46%
Volume 220.0K
MYGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 1:18 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for myriad genetics inc (MYGN)

Year over year, Myriad Genetics Inc. has been able to grow revenues from $496.0M USD to $613.2M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold, SGA expenses and income tax expenses. All of these improvements led to a bottom line growth from $112.2M USD to $147.1M USD.
Currency in
Millions of US Dollars
As of:Jun 30
2010
Jun 30
2011
Restated
Jun 30
2012
Restated
Jun 30
2013
4 Year
Trend
Revenues362.6402.1496.0613.2
TOTAL REVENUES362.6402.1496.0613.2
Cost of Goods Sold44.346.764.779.6
GROSS PROFIT318.4355.4431.3533.5
Selling General & Admin Expenses, Total161.4169.8208.4251.8
R&D Expenses21.927.842.652.2
OTHER OPERATING EXPENSES, TOTAL183.3197.6251.0304.1
OPERATING INCOME135.1157.8180.3229.5
Interest and Investment Income5.72.24.65.5
NET INTEREST EXPENSE5.72.24.65.5
Other Non-Operating Income (Expenses)0.1-0.4-0.4-0.2
EBT, EXCLUDING UNUSUAL ITEMS140.8159.7184.5234.8
Other Unusual Items, Total-------1.5
EBT, INCLUDING UNUSUAL ITEMS140.8159.7184.5233.3
Income Tax Expense-11.558.972.486.1
Earnings from Continuing Operations152.3100.7112.2147.1
NET INCOME152.3100.7112.2147.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS152.3100.7112.2147.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS152.3100.7112.2147.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYGN:US $37.55 USD +0.20

MYGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bio-Reference Labs Inc $30.90 USD +0.15
Foundation Medicine Inc $26.47 USD -0.88
Genomic Health Inc $26.59 USD -0.06
Imperial Innovations Group PLC 460.00 GBp 0.00
NeoGenomics Inc $5.36 USD +0.18
View Industry Companies
 

Industry Analysis

MYGN

Industry Average

Valuation MYGN Industry Range
Price/Earnings 16.0x
Price/Sales 3.6x
Price/Book 3.9x
Price/Cash Flow 15.1x
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYRIAD GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.